Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Epilepsia|May 19, 2015
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsyDwain Tolbert, James Cloyd, Victor Biton, et al.Neurotoxicology|April 9, 2011
Oral toxicity of vigabatrin in immature rats: characterization of intramyelinic edemaMark Walzer, Ihor Bekersky, Stephen Wanaski, et al.Cancer Research|January 15, 1995
Normocalcemic effect of gallium nitrate in a hypercalcemic rat modelJ R Lin, I Bekersky, N S Brown, et al.Bone Marrow Transplantation|March 5, 1998
Tacrolimus pharmacokinetics in BMT patientsG W Boswell, I Bekersky, J Fay, et al.Antimicrobial Agents and Chemotherapy|November 16, 2001
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose studyT J Walsh, J L Goodman, P Pappas, et al.Clinical Pharmacology and Therapeutics|February 17, 2001
The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groupsL M Mancinelli, L Frassetto, L C Floren, et al.Journal of Clinical Pharmacology|July 20, 2005
Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteersMary F Hebert, Robert W Townsend, Stephen Austin, et al.Transplantation|January 15, 1997
Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantationR W Gruessner, F M Uckun, J Pirenne, et al.Antimicrobial Agents and Chemotherapy|November 16, 2001
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbitsA H Groll, D Mickiene, V Petraitis, et al.Journal of Clinical Pharmacology|May 12, 2000
Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerabilityJ Pirsch, I Bekersky, F Vincenti, et al.Pageof 8